Second Annual Retreat

Transcription

1 Funding excellence. Uniting care. Second Annual Retreat Program Friday, September 16, 2016 Centre Mont-Royal 2200 Mansfield Street Montreal

2 2 Message from the Executive Committee of the Rossy Cancer Network It gives us great pleasure to welcome you to the second annual retreat of the Rossy Cancer Network (RCN). This event brings together clinicians, researchers and allied health professionals involved in cancer care in the McGill University-affiliated hospitals the McGill University Health Centre, the Jewish General Hospital and St. Mary s Hospital Center. As we look back at the work that has been undertaken in the past year, we are proud to say that cancer care in the RCN hospitals has never been as collaborative and unified. The Disease Site Program, the cornerstone of the RCN, now has seven Disease Site Teams with a representative membership of over 100 multi-disciplinary health care professionals, working together to streamline care in each of their respective disease sites (lung cancer, breast cancer, etc..). Thanks to their collaboration, a reinvigorated clinical trials program is now in place allowing patients to access leading-edge treatments across the network, regardless of their treating hospital. In addition to numerous patient experience initiatives undertaken by the RCN team with hospital collaborators, there are two years worth of Cancer Quality & Innovation (CQI) Education and Research Grants underway, with over 20 active projects. These involve 110 health professionals, including physicians, nurses, dietitians, psychosocial oncologists and rehabilitation professionals addressing quality across the continuum of care. With this foundation in place, we are proud to present the new RCN Operational Plan, which outlines our shared strategic priorities for the next five years (see page 4). We are poised to capitalize on our current momentum to ensure that patients receive timely access to high-quality care, and that they are supported and included in the planning of their care. Finally, we want to express our appreciation for taking time out of your busy schedules to attend the retreat. It is our firm belief that, thanks to your collaboration and insights, we can demonstrate what a unified centre of excellence in cancer care can achieve. Sincerest thanks, Dr. Armen Aprikian Dr. Gerald Batist Dr. Samuel Benaroya Dr. Eduardo Franco Dr. Adrian Langleben Dr. Ari Meguerditchian Dr. Wilson H. Miller, Jr. Agenda Friday, September 16, 2016 AGENDA 7:30 Registration and Breakfast [Foyer International] 8:30 8:40 9:05 9:25 9:40 Opening Remarks [Salon International] David Eidelman, Chair, RCN Governance Group; Dean, Faculty of Medicine, McGill University Keynote Speech: Working as a network Jean Latreille, Director, Direction générale de cancérologie RCN Strategic Direction Wilson Miller, RCN Clinical Lead EVIDENCE-BASED CARE ACCESS TO CARE Measures of Performance Gerald Batist, RCN Executive Committee; Director, Segal Cancer Centre, JGH Improving Surgical Outcomes Across the RCN Armen Aprikian, RCN Executive Committee; Chief, Cancer Mission, MUHC 9:50 Coffee Break and poster viewing [Foyer International] 10:05 Disease Site Program: Delivering Harmonized : RCN Disease Site Leads 11:50 Lunch and poster viewing [Foyer International] RESEARCH AND EDUCATION Cancer Quality and Innovation (CQI) Program and Announcement of 2016 CQI Research Grant Awardees 12:50 Ari Meguerditchian, CQI Program Lead, RCN; Surgical Oncologist, MUHC 13:05 CQI: Streamlining Trajectory for Oesophago-Gastric Cancer Lorenzo Ferri, CQI Research Grant Recipient; Surgical Oncologist, MUHC Quality Improvement Initiatives Fund (QI 2 ): Male Fertility Preservation María Belén Hererro, QI 2 Grant Recipient; MUHC Reproductive Centre PATIENT EXPERIENCE 13:25 Treatment Summary Pilot: Facilitating Communication Between Oncologists and Primary Adrian Langleben, RCN Executive Committee; Chief, Cancer, SMHC Radiation-Oncology Portal: Connecting s to Information 13:35 John Kildea, Project co-lead; Medical Physicist, MUHC YOUR VOICE: FEEDBACK AND QUESTIONS 14:00 Breakout Sessions: 1. ACCESS TO CARE How to Provide Urgent Services Across the Network [Salon International 2] Moderator: Ari Meguerditchian. Project Co-Leads: Erin Cook, Head Nurse in Oncology, JGH / Andréane Chevrette, Assistant Head Nurse, Oncology Day Centre, MUHC. Panelists: Sarit Assouline, RCN Hematology Disease Site Co-Lead; Hematologist, JGH / Raghu Rajan, Lower GI Site Lead, MUHC. 2. PATIENT EXPERIENCE Integrating Supportive Programs: Enhancing Psychosocial, Palliative and Survivorship Initiatives Within the RCN [Salon Cartier 1] RCN Supportive Co-Leads: Zeev Rosberger, Director, Psychosocial Oncology, JGH / Manuel Borod, Director, Supportive and Palliative, MUHC 3. LEADING-EDGE TREATMENTS Bringing Leading-Edge Treatments to All s [Salon International 1] Adrian Langleben, RCN Executive Committee; Chief, Cancer, St. Mary s Hospital / Petr Kavan, RCN GI Disease Site Co-Lead; Director, Clinical Research Program, JGH / Thierry Alcindor, RCN GI Disease Site Co-Lead; Associate Director, Clinical Trials in Oncology, Centre for Innovative Medicine, MUHC 3

3 RCN Strategic Direction Statement RCN Strategic Priorities A world-class cancer network provides the highest standard of care and the best possible cancer experience to its patients. It is a magnet for excellent health care professionals, a leader in research and education, and strives to continually improve its cancer services. The VISION of the Rossy Cancer Network (RCN) is to become a world-class comprehensive cancer network with outcomes in cancer survival, mortality, and patient satisfaction as good as or better than those of the leading international comprehensive cancer centres. Our MISSION is to improve the quality of cancer care received by the population served by the McGill Academic Health Network. We will achieve this through a multi-faceted approach and strong inter-organizational governance among the RCN s member organizations McGill University Health Centre, Jewish General Hospital and St. Mary s Health Center with optimal use of resources available at these institutions and the trust and willingness to achieve shared strategic goals. Five strategic priorities ( Experience, Evidence-Based,, Leading-Edge Treatments, Research & Education) will anchor our decision making and provide a blueprint for focused initiatives that aim to achieve the following shared goals: Outstanding patient support with measured improvement in patient engagement and experiences. A common scorecard with accountability and transparency driving continuous evidence-based quality improvements in patient care. Improved access and reduced wait times for diagnostic, treatment and supportive services along the cancer care continuum. Earlier access to breakthrough treatments for patients. Measured improvements in care and scholarly output, through research and education. Experience Evidence- Based Leading-Edge Treatments Research & Education Outstanding patient support with measured improvement in patient engagement and experiences. Continuous improvements in patient care supported by a common scorecard. Improved access and reduced wait times for diagnostic, treatment and supportive services along the cancer care continuum. Earlier access to breakthrough treatments for patients. Research and education generating measured improvements in care and scholarly output. The Disease Site groups will provide strong clinical leadership structures and will work together, across institutions in a collaborative and integrative fashion, to continuously improve patient care. They will be advocates for a culture of rigorous self-evaluation, tracking outcomes and indicators, and global benchmarking of performance. Finally, they will ensure that patients have access to the latest scientific knowledge and innovations to obtain the most effective treatments. Experience 2016 Rossy Cancer Network Strategic Priorities Evidence- Based Leading-Edge Treatments Research & Education Targeted quality improvements will be supported by all inter-hospital governance, including the oncology leads, quality improvement managers, and the director generals of the hospitals who will remove barriers when needed. We will continue to empower front-line oncology professionals to develop new knowledge on cancer care quality and enhance their skills in fields pertinent to cancer care quality. Finally, since we have aligned some of our strategic priorities with those of the Health Ministry of Quebec and the Direction générale de cancérologie, we will work collaboratively to address major issues in cancer care quality and to support performance improvements through investment in IT platforms within the Rossy Cancer Network. By working together and being purposeful about implementing this strategic vision, we will better address patients needs across the continuum of cancer care and serve as a transformative resource and model for cancer control efforts in Quebec and in Canada. When framed by this strategic vision, the critical choices we make will allow us to make great strides to achieving world-class cancer care. Respond to Needs Ensure Quality of Promote Optimize Trajectory Cancer Prevention 2015 Priorities of the Direction générale de cancérologie (MSSS) Cancer Screening 4 5

4 RCN Team Contact details can be found on mcgill.ca/rcr-rcn/contact-us. DISEASE SITE PROGRAM Wilson Miller, MD, PhD Karla Esquivel, CPA, CA Caroline Rousseau, PhD Mohammad Afshin, MD Clinical Lead Finance Manager Senior Clinical Manager Disease Site Program Manager and RCN Scorecard. Disease Site Facilitator Genitourinary Collection of data for the kidney cancer database and for scorecard indicators. Administrative and quality improvement project support. Ari Meguerditchian, MD Sophie Lorenzo Cancer, Quality and Innovation (CQI) Program Lead Communications Officer Mitali Ruths, MD Sarita Benchimol, MSc Clinical Liaison Clinical research and metrics. Disease Site Facilitator Breast, Hematology, Gastrointestinal Collection of data for scorecard indicators. Administrative and quality improvement project support. Tony Teti Ana Pauna Director of Operations Administrator Alla a Ali, PhD Melanie Lane, Disease Site Program Quality improvement projects. Disease Site Facilitator - Head & Neck, Lung and Gynecology Collection of data for scorecard indicators. Administrative and quality improvement project support. PROJECT MANAGEMENT DATA & ANALYTICS Sandrine Camera, MPA Myriam Fernandez CQI program and NSQIP project. Data Analyst Extracting and consolidating data for scorecard indicators and RCN projects. Cancer registrar - JGH Adriana Krasteva, MHA Warren Sateren, MPH, MBA Angelle Lévesque, CTR Epidemiologist AOPSS project and data analytics for scorecard and RCN projects. Cancer registrar - MUHC Supportive Program, ipehoc, and QI2 projects (Urgent Centre, Start the Talk). Hélène Malouin, CTR Gligorka Raskovic, MHA Finding Common Ground and QI2 projects (Male Fertility Preservation, Adolescent & Young Adult program). 6 7

5 Announcements New cancer clinical trials website for McGill-affiliated hospitals Want to be the first to know about the next round of CQI funding? Cancer Quality and Innovation Research Grants The RCN has created a new web page which centralizes information about new, exciting, experimental treatments. The web page at mcgill.ca/rcr-rcn/clinical-trials lists trials by disease site and includes key information such as the principal investigator, trial coordinator contact information, and a link to the Clinicaltrials.gov site for more details. Through this central repository, the RCN seeks to foster joint partnerships among hospitals and give patients the opportunity to access the most advanced therapies. Get the news in your inbox! Subscribe to our newsletter online at mcgill.ca/rcr-rcn/subscribe-rcn-newsletter. Or follow us on facebook.com/rcr.rcn Photo Release Statement The RCN may use photos from its annual retreat in future promotional materials. By virtue of your attendance, it is assumed that you agree to the usage of your likeness in such materials. If you do object to having your photo taken, please advise the photographer. Keep in touch! Like the RCN page at facebook.com/rcr.rcn and keep abreast of announcements and new editions of the RCN newsletter. mcgill.ca/rcr-rcn facebook.com/rcr.rcn Rossy Cancer Network 2155 Guy Street, Suite 224 Montreal, Qc, H3H 2R x